456 related articles for article (PubMed ID: 27322698)
21. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
[TBL] [Abstract][Full Text] [Related]
23. Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors.
Crippa S; Partelli S; Zamboni G; Scarpa A; Tamburrino D; Bassi C; Pederzoli P; Falconi M
Surgery; 2014 Jan; 155(1):145-53. PubMed ID: 24646958
[TBL] [Abstract][Full Text] [Related]
24. A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands.
Genc CG; Klümpen HJ; van Oijen MGH; van Eijck CHJ; Nieveen van Dijkum EJM
World J Surg; 2018 Feb; 42(2):490-497. PubMed ID: 29018912
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes.
Luo G; Fan Z; Gong Y; Jin K; Yang C; Cheng H; Huang D; Ni Q; Liu C; Yu X
Pancreas; 2019 Jul; 48(6):817-822. PubMed ID: 31210663
[TBL] [Abstract][Full Text] [Related]
26. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
27. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Karaman K; Bostanci EB; Aksoy E; Kurt M; Celep B; Ulas M; Dalgic T; Surmelioglu A; Hayran M; Akoglu M
Eur J Intern Med; 2011 Dec; 22(6):e95-8. PubMed ID: 22075321
[TBL] [Abstract][Full Text] [Related]
28. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
29. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract][Full Text] [Related]
30. Natural History and Treatment Trends in Pancreatic Cancer Subtypes.
Pokrzywa CJ; Abbott DE; Matkowskyj KA; Ronnekleiv-Kelly SM; Winslow ER; Weber SM; Fisher AV
J Gastrointest Surg; 2019 Apr; 23(4):768-778. PubMed ID: 30706376
[TBL] [Abstract][Full Text] [Related]
31. Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients.
Fathi AH; Romanyshyn J; Barati M; Choudhury U; Chen A; Sosa JA
Am Surg; 2020 May; 86(5):458-466. PubMed ID: 32684030
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.
Mpilla GB; Philip PA; El-Rayes B; Azmi AS
World J Gastroenterol; 2020 Jul; 26(28):4036-4054. PubMed ID: 32821069
[TBL] [Abstract][Full Text] [Related]
33. National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors.
Kasumova GG; Tabatabaie O; Eskander MF; Tadikonda A; Ng SC; Tseng JF
J Am Coll Surg; 2017 Jun; 224(6):1057-1064. PubMed ID: 27965134
[TBL] [Abstract][Full Text] [Related]
34. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
[TBL] [Abstract][Full Text] [Related]
36. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
37. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
[TBL] [Abstract][Full Text] [Related]
38. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
[TBL] [Abstract][Full Text] [Related]
39. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States.
Liu X; Chen B; Chen J; Su Z; Sun S
J Endocrinol Invest; 2023 Jul; 46(7):1373-1384. PubMed ID: 36522587
[TBL] [Abstract][Full Text] [Related]
40. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
